Comparative efficacy of biologics as monotherapy and in combination with methotrexate on patient reported outcomes (PROs) in rheumatoid arthritis patients with an inadequate response to conventional DMARDs – a systematic review and network meta-analysis

@inproceedings{Jansen2014ComparativeEO,
  title={Comparative efficacy of biologics as monotherapy and in combination with methotrexate on patient reported outcomes (PROs) in rheumatoid arthritis patients with an inadequate response to conventional DMARDs – a systematic review and network meta-analysis},
  author={Jeroen P. Jansen and Felicity Buckley and Fred Dejonckheere and Sarika S Ogale},
  booktitle={Health and quality of life outcomes},
  year={2014}
}
OBJECTIVE To compare biologics as monotherapy or in combination with methotrexate (MTX) in terms of patient reported outcomes (PROs) in RA patients with an inadequate response to conventional DMARDs (DMARD-IR). METHODS With a systematic literature review 17 RCTs were identified that evaluated adalimumab, certolizumab pegol, etanercept, golimumab, infliximab, abatacept, anakinra or tocilizumab. Treatment effects in terms of pain (0-100 mm), patient's global assessment of disease activity (PGA… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 1 time over the past 90 days. VIEW TWEETS
15 Citations
61 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 15 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 61 references

SF-36 Physical and Mental Health Summary Scales: a User’s Manual. Boston: New England Medical Center, The Health Institute

  • JE Ware, M Kosinski, SK Keller
  • 1994
Highly Influential
20 Excerpts

Similar Papers

Loading similar papers…